Comparative Evaluation of Profiles of Antibodies to Mycobacterial Capsular Polysaccharides in Tuberculosis Patients and Controls Stratified by HIV Status
- 1 February 2012
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (2), 198-208
- https://doi.org/10.1128/cvi.05550-11
Abstract
Despite the complexity of tuberculosis (TB) serology, antibodies (Abs) remain attractive biomarkers for TB. Recent evidence of a mycobacterial capsule that consists mainly of the polysaccharides arabinomannan (AM) and glucan provides new options for serologic targets. For this study, Ab responses to AM and glucan for 47 U.S. TB patients (33 HIV negative [HIV − ], 14 HIV positive [HIV + ]), 42 healthy controls, and 38 asymptomatic HIV + controls were evaluated by enzyme-linked immunosorbent assays (ELISAs). The results were compared with Ab responses to the mycobacterial glycolipid cell wall antigen lipoarabinomannan (LAM) and to the proteins malate synthase (MS) and MPT51. We found that the main immunoglobulin (Ig) isotype response to polysaccharides was IgG, predominantly of subclass IgG2. IgG responses to AM were significantly higher for HIV − and HIV + TB cases than for controls ( P , − than for HIV + TB cases ( P , − and HIV + cases ( P , 0.01 and 0.02, respectively). In both TB groups, titers of Ab to glucan were significantly lower than titers of Ab to AM ( P , − TB patients, while they correlated significantly in HIV + TB patients ( P , 0.01 and 0.05, respectively). We conclude that Ab responses to AM could contribute to the serodiagnosis of TB, especially for HIV − TB patients. This study also provides new and important insights into the differences in the profiles of Abs to mycobacterial antigens between HIV − and HIV + TB patients.Keywords
This publication has 53 references indexed in Scilit:
- Incipient and Subclinical Tuberculosis: Defining Early Disease States in the Context of Host Immune ResponseThe Journal of Infectious Diseases, 2011
- Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in miceJCI Insight, 2011
- Correlation between Serum and Plasma Antibody Titers to Mycobacterial AntigensClinical and Vaccine Immunology, 2011
- Dynamic antibody responses to the Mycobacterium tuberculosis proteomeProceedings of the National Academy of Sciences of the United States of America, 2010
- Antibodies against Immunodominant Antigens of Mycobacterium tuberculosis in Subjects with Suspected Tuberculosis in the United States Compared by HIV StatusClinical and Vaccine Immunology, 2010
- Development of a Murine Mycobacterial Growth Inhibition Assay for Evaluating Vaccines againstMycobacterium tuberculosisClinical and Vaccine Immunology, 2009
- Performance of Purified Antigens for Serodiagnosis of Pulmonary Tuberculosis: a Meta-AnalysisClinical and Vaccine Immunology, 2009
- Biomarkers for Clinical and Incipient Tuberculosis: Performance in a TB-Endemic CountryPLOS ONE, 2008
- Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic ReviewPLoS Medicine, 2007
- Dynamic Changes in Pro- and Anti-Inflammatory Cytokine Profiles and Gamma Interferon Receptor Signaling Integrity Correlate with Tuberculosis Disease Activity and Response to Curative TreatmentInfection and Immunity, 2007